top of page

Search Results

Results found for "University of California"

Posts (115)

View All

Other Pages (209)

  • Structure-based discovery of functionally selective 5-HT1A receptor agonists

    Peter Gmeiner received his Ph.D. from the University of Munich. He was a postdoc at the University of California in Berkeley, USA. Habilitus, he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining an offer for a professorship at the University of Heidelberg, at the same time. Erlangen-Nürnberg and declined an offer for the Chair for Pharmaceutical Chemistry at the University

  • Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    About Yimin Zou "I received Ph.D from University of California at Davis and San Diego in 1995 and then postdoctoral training from University of California, San Francisco in 2000. I was an assistant and then associate professor with tenure at the University of Chicago from 2000 to 2006 and moved to University of California San Diego as an Associate Professor in 2006. Javitch in the Department of Psychiatry at Columbia University Irving Medical Center."

  • G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies

    Pharmacology, School of Medicine, and Associate Director for Basic Science at the Moores Cancer Center, University of California San Diego (UCSD).

View All
bottom of page